BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Amarin And FDA Reaffirm Concurrence On REDUCE-IT Through Special Protocol Assessment Agreement Amendment

  August 4, 2016

   · 

  14 min read
• Bio NC

  Patheon Announces Full Redemption Of 8.75%/9.50% Senior PIK Toggle Notes Due May 1, 2020

  August 4, 2016

   · 

  1 min read
• Business

  Johnson & Johnson Snags 5-Year, $60 Million Supply Dod Contract

  August 4, 2016

   · 

  1 min read
• Osprey Med Announces Oversubscribed A$28 Million Private Placement

  August 4, 2016

   · 

  4 min read
• Drug Development

  Momenta Halts Enrollment in Necuparanib Phase II Per Recommendation From the Independent Data Safety Monitoring Board

  August 4, 2016

   · 

  4 min read
• Business

  Two Former Shire Execs Join Chronos Therapeutics as New VPs for Multiple Schlerosis and PTSD Research

  August 4, 2016

   · 

  2 min read
• Biotech Bay

  Gilead Pounces Back as BMJ Report on Its Pricing of Drugs Hit a Nerve

  August 4, 2016

   · 

  1 min read
• Pharm Country

  FDA Hits Adaptimmune with a Partial Hold on Pivotal Sarcoma Trial, Stock Tanks

  August 4, 2016

   · 

  3 min read
• Biotech Bay

  Drugmakers Like AbbVie, Bayer Turn Their Eyes to Women’s Health and a Disease With $78 Billion Cost Draws

  August 4, 2016

   · 

  1 min read
• Deals

  Avara Picks Up Astellas’ U.S. Manufacturing Facility

  August 4, 2016

   · 

  1 min read